ThinkstockCancer treatment developer Exelixis Inc. (NASDAQ: EXEL) is trading very heavy volume today and getting a sharp price boost following a positive result in a phase 3 pivotal trial of a combination…
Paul Ausick Exelixis may have a while longer before it gets to be a serious revenue stage company. Its stock was crushed on Wednesday, and the company has lost its $1 billion market cap.
Jon C. Ogg The Quantitative Strategies team at Jefferies closely monitors the index changes. 24/7 Wall St. screened the Jefferies list of stocks that will see major position adds for the rebalance. Some of them…
Piper Jaffray analyst have a list of top biotech stock picks that could bring big gains for investors. The look for high-conviction near-term binary events and lower conviction catalysts with negligible downside.
ThinkstockBiotechnology stocks have had an extremely solid first half of the year. The analysts at Cowen Group point out that expectations are very high and many of the stocks have already made…
We are now just about two weeks away from the king of biotech and pharma events in cancer treatments. The 2012 annual meeting of the American Society of Clinical Oncology (ASCO) is set…
It is now getting close to the middle of May, and that means one thing for biotech investors. The king of biotech and pharma events is about to take place. The 2012…
Jon OggThese are some of the top analyst upgrades, downgrades, and initiations seen from Wall Street brokerage and research firms this Tuesday morning. Amgen Inc. (NASDAQ: AMGN) Reiterated Buy and Raised target to…
The markets are beyond jittery. From a massively overbought market discounting a recession entirely back to a market dominated by the woes of Europe. The Europeans cannot get their bailouts straight because each…
Active traders and day traders have many stocks to choose from this Tuesday morning. We are tracking news and moves in shares of Allied Irish Bank (NYSE: AIB), ARM Holdings PLC (NASDAQ: ARMH), Exelixis, Inc.…
Active traders and day traders have many stocks to choose from this Thursday morning. We are tracking news and moves in shares of Dry Ships, Inc. (NASDAQ: DRYS), Exelixis, Inc. (NASDAQ: EXEL), Humana, Inc.…
There were many stocks in Biotech and BioHealth with plus-signs after their share prices today. The BioHealth Business Daily is smoothing out the brief winners and losers to only weed out the…
The following are some of the top stocks to watch for active trading today based on pre-market and after-hours volume activity. There are links through to more detailed coverage and volume analysis…
We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data presentations slated to start this weekend. This is broken down in drug…
We are just about to get the first round of abstracts from companies presenting data at this year’s American Society of Clinical Oncology meeting for 2009. At BioHealthInvestor.com we compiled a brief…
